{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:01:05Z","timestamp":1788865265726,"version":"build-2803163510"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R15 AI 060356-01"],"award-info":[{"award-number":["R15 AI 060356-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R15 CA 136901"],"award-info":[{"award-number":["R15 CA 136901"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cellimm.2023.104788","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:13:40Z","timestamp":1700622820000},"page":"104788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Loss of B1 and marginal zone B cells during ovarian cancer"],"prefix":"10.1016","volume":"395-396","author":[{"given":"Jeffrey","family":"Maslanka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretel","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Londregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Silberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.cellimm.2023.104788_b0005","doi-asserted-by":"crossref","first-page":"e130621","DOI":"10.1172\/jci.insight.130621","article-title":"Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation","volume":"4","author":"Shukla","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0015","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41467-019-09010-6","article-title":"Stem cell proliferation is induced by apoptotic bodies from dying cells during epithial tissue maintenance","volume":"10","author":"Brock","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2023.104788_b0020","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.aaf9011","article-title":"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention","volume":"355","author":"Tomasetti","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2023.104788_b0025","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cellimm.2023.104788_b0035","doi-asserted-by":"crossref","unstructured":"G.M. Rodriguez, K.J.C. Galpin, C.W. McCloskey, B.C. Vanderhyden, The tumor microenvironment of epithelial ovarian cancer and its influence on response to immunotherapy, Cancers (Basel) 10(8) (2108) 242-250. https:\/\/pubmed.ncbi.nlm.nih.gov\/30042343\/.","DOI":"10.3390\/cancers10080242"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/path.4002","article-title":"The peritoneal tumour microenvironment of high-grade serous ovarian cancer","volume":"227","author":"Leinster","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.cellimm.2023.104788_b0045","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.2147\/CMAR.S210568","article-title":"Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cellimm.2023.104788_b0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1757-2215-6-63","article-title":"Tracking NF-kB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model","volume":"6","author":"Wilson","year":"2013","journal-title":"J. Ovarian Res."},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4049\/jimmunol.2200074","article-title":"Innate and innate-like effector lymphocytes in health and disease","volume":"209","author":"van Kaer","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2018.12.001","article-title":"B-1 cell responses to infections","volume":"57","author":"Smith","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0070","unstructured":"CBA\/CaHN-Btkxid\/J, Strain #: 001011. https:\/\/www.jax.org\/strain\/001011."},{"issue":"12","key":"10.1016\/j.cellimm.2023.104788_b0075","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.dci.2006.03.007","article-title":"Spiny mice (Acomys cahirinus) do not respond to thymus-independent type 2 antigens","volume":"30","author":"Pennello","year":"2006","journal-title":"Dev. Comp. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0080","first-page":"516","article-title":"Behavioral, clinical, and physiologic analysis of mice used for ascites monoclonal antibody production","volume":"50","author":"Peterson","year":"2000","journal-title":"Comp. Med."},{"issue":"11","key":"10.1016\/j.cellimm.2023.104788_b0085","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1158\/1940-6207.CAPR-13-0227","article-title":"The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis","volume":"6","author":"Cohen","year":"2013","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1074-7613(01)00129-7","article-title":"Marginal zone and B1 B cells unite in the early response against T-independent blood-borne antigens","volume":"14","author":"Martin","year":"2001","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2023.104788_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-3532-1_1","article-title":"B cell development and maturation","volume":"1254","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/j.cellimm.2023.104788_b0105","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.4049\/jimmunol.167.12.6834","article-title":"Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation","volume":"167","author":"Allman","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0110","doi-asserted-by":"crossref","first-page":"e20202700","DOI":"10.1084\/jem.20202700","article-title":"Natural history of MZ B cells","volume":"218","author":"Nemazee","year":"2021","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2023.104788_b0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","article-title":"Functional states of myeloid cells in cancer","volume":"41","author":"van Vlerken-Ysla","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellimm.2023.104788_b0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cellimm.2017.02.002","article-title":"Macrophage regulation of B cell proliferation","volume":"314","author":"Goldman","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2567.2005.02312.x","article-title":"Peritoneal macrophages suppress T-cell activation by amino acid catabolism","volume":"117","author":"Matlack","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2023.104788_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2023.104788_b0135","first-page":"87","article-title":"X-linked immune deficiency (xid) of CBA\/N mice","volume":"124","author":"Wicker","year":"1986","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1994.tb00844.x","article-title":"X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene","volume":"138","author":"Conley","year":"1994","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.cellimm.2023.104788_b0145","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.molimm.2006.11.023","article-title":"Btk regulates multiple stages in the development and survival of B-1 cells","volume":"44","author":"Contreras","year":"2007","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2023.104788_b0150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-15-0827","article-title":"Bruton-tyrosine kinase-dependent immune cell cross-talk drives pancreas cancer","volume":"6","author":"Gunderson","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellimm.2023.104788_b0155","doi-asserted-by":"crossref","unstructured":"A. Stiff, P. Trikha, R. Wesolowski, K. Kendra, V. Hsu, S. Uppati, E. McMichael, M. Duggan, A. Campbell, K. Keller, I. Landi, Y. Zhong, J. Dubovsky, J. Harrison Howard, L. Yu, B. Harrington, M. Old, S. Reiff, T. Mace, S. Tridandapani, N. Muthusamy, M.A. Caligiuri, J.C. Byrd, W.E. Carlson, 3rd, Myeloid-derived suppressor cells express Bruton\u2019s tyrosine kinase and can be depleted in tumor-bearing hosts by ibrutinib treatment, Cancer Res 76(8) (2016) 2125-2136. https:\/\/pubmed.ncbi.nlm.nih.gov\/26880800\/.","DOI":"10.1158\/0008-5472.CAN-15-1490"},{"key":"10.1016\/j.cellimm.2023.104788_b0160","first-page":"40","article-title":"B cell regulation of the anti-tumor response and role in carcinogenesis, J Immunother 4","author":"Schwartz","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0165","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood-2004-01-0207","article-title":"Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses","volume":"104","author":"Mangla","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10495-010-0569-6","article-title":"Role of Bruton\u2019s tyrosine kinase in macrophage apoptosis","volume":"16","author":"Khare","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.cellimm.2023.104788_b0175","doi-asserted-by":"crossref","unstructured":"J.J. Mond, P.K. Mongini, D. Sieckmann, W.E. Paul, Role of T lymphocytes in the response to TNP-AECM-Ficoll, 125(3) (1980) J Immunol 1066-1070.","DOI":"10.4049\/jimmunol.125.3.1066"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1084\/jem.157.1.202","article-title":"The \u201cLy-1 B\u201d cell subpopulation in normal immunodefective, and autoimmune mice","volume":"157","author":"Hayakawa","year":"1983","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","article-title":"Current insights into the metastasis of epithelial ovarian cancer- hopes and hurdles","volume":"43","author":"Yousefi","year":"2020","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.cellimm.2023.104788_b0190","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fimmu.2019.01273","article-title":"Myeloid derived suppressor cells: key drivers of immunosuppression in ovarian cancer","volume":"10","author":"Baert","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ajpath.2013.04.023","article-title":"Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models","volume":"183","author":"Clark","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/JLB.5MIR0720-271RR","article-title":"Specialized immune responses in the peritoneal cavity and omentum","volume":"109","author":"Liu","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.cellimm.2023.104788_b0210","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1084\/jem.20061041","article-title":"Regulation of B1 cell migration by signals through Toll-like receptors","volume":"203","author":"Ha","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0215","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2353\/ajpath.2006.051222","article-title":"Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment","volume":"169","author":"Gerber","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"7280","key":"10.1016\/j.cellimm.2023.104788_b0220","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.cellimm.2023.104788_b0235","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/2326-6066.CIR-21-0880","article-title":"Circulating Tregs accumulate in omental tumors and acquire adipose-resident features","volume":"10","author":"Liu","year":"2022","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0245","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.20170771","article-title":"B1a B cells require autophagy for metabolic homeostasis and self-renewal","volume":"215","author":"Clarke","year":"2018","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104788_b0250","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","article-title":"B1 and marginal zone B cells but not follicular B2 require Gpx4 to prevent lipid peroxidation and ferroptosis","volume":"29","author":"Muri","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2023.104788_b0255","unstructured":"S.S. Chen, G. Spiegel, Stage I endometrial carcinoma. Role of omental biopsy and omentectomy, J Reprod Med 36(9) 627-629. https:\/\/pubmed.ncbi.nlm.nih.gov\/1774722\/."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104788_b0260","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00262-005-0101-y","article-title":"Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease","volume":"55","author":"Oosterling","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0265","doi-asserted-by":"crossref","first-page":"e20191869","DOI":"10.1084\/jem.20191869","article-title":"Tissue-resident macrophage in omentum promote metastatic spread of ovarian cancer","volume":"217","author":"Etzerodt","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104788_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.678127","article-title":"B cell orchestration of anti-tumor immune responses: a matter of cell localization and communication","author":"Kinker","year":"2021","journal-title":"Front Cell Dev Biol 9"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/0008-5472.CAN-18-0981","article-title":"Activation of B-1 cells promotes tumor cell killing in the peritoneal cavity","volume":"79","author":"Haro","year":"2019","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cellimm.2023.104788_b0280","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00262-020-02607-7","article-title":"A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells","volume":"69","author":"Dyevoich","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2023.104788_b0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","article-title":"Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer","volume":"905","author":"Fang","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0290","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.176.1.284","article-title":"Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression","volume":"176","author":"Bunt","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0295","doi-asserted-by":"crossref","unstructured":"S. Miyamoto, L. Renee Ruhaak, C. Stroble, M.R. Salemi, B. Phinney, C.B. Lebrilla, G.S. Leiserowitz, Glycoproteomic analysis of malignant ovarian cancer ascites fluid identifies unusual glycopeptides, J Proteome Res 15(9) (2016) 3358-3376. https:\/\/pubmed.ncbi.nlm.nih.gov\/27500424\/.","DOI":"10.1021\/acs.jproteome.6b00548"},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0300","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ijc.2910160510","article-title":"Isolation of tumor-specific antibodies from effusions of ovarian carcinomas","volume":"16","author":"Dorsett","year":"1975","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0305","first-page":"644","article-title":"Antibody cytotoxicity studies in ovarian and cervical malignancies","volume":"42","author":"Disaia","year":"1973","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0310","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4049\/jimmunol.172.1.625","article-title":"Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells","volume":"172","author":"Qian","year":"2004","journal-title":"J. Immunol."},{"issue":"6373","key":"10.1016\/j.cellimm.2023.104788_b0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/357077a0","article-title":"Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice","volume":"357","author":"Murakami","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104788_b0320","doi-asserted-by":"crossref","first-page":"1089410","DOI":"10.3389\/fimmu.2022.1089410","article-title":"Exosomes: a potential tool for immunotherapy of ovarian cancer","volume":"13","author":"Gong","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0325","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4049\/jimmunol.1400643","article-title":"Extravascular red blood cells and hemoglobin promote tumor growth and therapeutic resistance as endogenous danger signals","volume":"194","author":"Yin","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0330","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4049\/jimmunol.171.1.317","article-title":"Plasmodium chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution","volume":"171","author":"Achtman","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0335","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/534697","article-title":"Acute disruption of bone marrow lymphopoiesis and apoptosis of transitional and marginal zone B cells in the spleen following a blood-stage Plasmodium chabaudi infection in mice","author":"Bockstal","year":"2011","journal-title":"J Parasitol Res 534697"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/expr.2001.4622","article-title":"Plasmodium chabaudi chabaudi: B-1 cell expansion correlates with semiresistance in BALB\/cJ mice","volume":"98","author":"Yoder","year":"2001","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cellimm.2023.104788_b0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcdb.2015.01.009","article-title":"Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocytic death","volume":"39","author":"Lang","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.cellimm.2023.104788_b0350","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/iub.106","article-title":"Erythrocyte programmed cell death","volume":"60","author":"Foller","year":"2008","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0355","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4049\/jimmunol.1602056","article-title":"B-1a cells protect mice from sepsis: critical role of CREB","volume":"199","author":"Aziz","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0360","doi-asserted-by":"crossref","first-page":"e0227707","DOI":"10.1371\/journal.pone.0227707","article-title":"Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer","volume":"15","author":"Miao","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cellimm.2023.104788_b0365","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cancers14123022","article-title":"Influences of gastrointestinal microbiota dysbiosis on serum proinflammatory markers in epithelial ovarian cancer development and progression","volume":"14","author":"Mahoney","year":"2022","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.cellimm.2023.104788_b0370","doi-asserted-by":"crossref","first-page":"e47015","DOI":"10.7554\/eLife.47015","article-title":"B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota","volume":"8","author":"Sm Kreuk","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.cellimm.2023.104788_b0375","doi-asserted-by":"crossref","unstructured":"K.L. Singel, K.S. Grzankowski, A.N.M. Nazmul H. Khan, M.J. Grimm, A.C. D\u2019Auria, K. Morrell, K.H. Eng, B. Hylander, P.C. Mayor, T.R. Emmons, N. Lenart, R. Fekete, Z. Kornyei, U. Muthukrishnan, J.D. Gilthorpe, C.F. Urban, K. Itagaki, C.J. Hauser, C. Leifer, K.B. Moyisch, K. Odunsi, A. Denes, B.H. Segal, Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer, Br J Cancer 120(2) (2019) 207-217. https:\/\/pubmed.ncbi.nlm.nih.gov\/30518816\/.","DOI":"10.1038\/s41416-018-0339-8"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104788_b0380","first-page":"3093","article-title":"Association between the HMGB1\/TLR4 signaling pathway and the clinicopathological features of ovarian cancer","volume":"18","author":"Jiang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104788_b0385","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00262-008-0650-y","article-title":"Toll-like receptor expression in normal ovary and ovarian tumors","volume":"58","author":"Zhou","year":"2009","journal-title":"Cancer Immunol Immunothera"},{"key":"10.1016\/j.cellimm.2023.104788_b0390","doi-asserted-by":"crossref","first-page":"1072670","DOI":"10.3389\/fphar.2022.1072670","article-title":"The emerging roles of TLR and cGAS signaling in tumorigenesis and progression of ovarian cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s10020-021-00295-2","article-title":"The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling","volume":"27","author":"Sipos","year":"2021","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2023.104788_b0400","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.4049\/jimmunol.0901297","article-title":"Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area","volume":"183","author":"Weiss","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0405","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/imm.13464","article-title":"NK-cell exhaustion, B-Cell Exhaustion, and T-Cell Exhaustion- the Differences and the Similarities","volume":"166","author":"Roe","year":"2022","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.cellimm.2023.104788_b0410","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.21037\/tcr-21-1152","article-title":"A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients","volume":"10","author":"Peng","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104788_b0415","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/eji.1830270935","article-title":"Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory reponses","volume":"27","author":"Oliver","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2023.104788_b0420","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.4049\/jimmunol.177.6.3791","article-title":"Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity","volume":"17","author":"Gunn","year":"2006","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2023.104788_b0425","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.4049\/jimmunol.1700943","article-title":"A Hard(y) look at B-1 cell development and function","volume":"199","author":"Baumgarth","year":"2017","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2023.104788_b0430","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.4049\/jimmunol.1001271","article-title":"Alterations in marginal zone macrophages and marginal zone B cells in old mice","volume":"186","author":"Birjandi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2018.09.019","article-title":"From zero to sixty and back to zero again: the metabolic life of B cells","volume":"57","author":"Akkaya","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2023.104788_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2018.11.003","article-title":"Cross-talk between signal transduction and metabolism in B cells","volume":"201","author":"Jellusova","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellimm.2023.104788_b0445","doi-asserted-by":"crossref","unstructured":"V. Plackoska, D. Shaban, A. Nijnik, Hematologic dysfunction in cancer: mechanisms, effects on antitumor immunity, and roles in disease progression, 13 Front Immunol (2022) 1041010. https:\/\/pubmed.ncbi.nlm.nih.gov\/36561751\/.","DOI":"10.3389\/fimmu.2022.1041010"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0450","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1038\/s41467-022-33117-y","article-title":"Cancer co-opts differentiation of B-cell precursors into macrophage-like cells","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0455","doi-asserted-by":"crossref","first-page":"e20221221","DOI":"10.1084\/jem.20221221","article-title":"Myeloid-like B cells boost emergency myelopoiesis through IL-10 production during infection","volume":"220","author":"Kanayama","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104788_b0460","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2023.104788_b0465","doi-asserted-by":"crossref","unstructured":"D.L. Moughon, H. He, S. Schokrpur, Z. Karen Jiang, M. Yaqoob, J. David, C. Lin, M. Luisa Iruela-Arispe, O. Dorigo, L. Wu, Macrophage blockade using CSF1R inhibitors reverses the vascular leakage underlying malignant ascites in late-stage epithelial ovarian cancer, Cancer Res 75(22) (2015) 4742-4752. https:\/\/pubmed.ncbi.nlm.nih.gov\/26471360\/.","DOI":"10.1158\/0008-5472.CAN-14-3373"},{"issue":"44","key":"10.1016\/j.cellimm.2023.104788_b0470","doi-asserted-by":"crossref","first-page":"76843","DOI":"10.18632\/oncotarget.20164","article-title":"Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-\/low myeloid-derived suppressor cells in ovarian cancer patients","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0475","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1078-0432.CCR-16-0387","article-title":"Expression of vascular endothelial growth factor in ovarian cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells","volume":"23","author":"Horikawa","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2023.104788_b0480","doi-asserted-by":"crossref","unstructured":"Y. Wang, C.C. Schafer, K.P. Hough, S. Tousif, S.R. Duncan, J.F. Kearney, S. Ponnazhagan, H-C. Hsu, J.S. Deshane, Myeloid-derived suppressor cells impair B cell responses in lung cancer through IL-7 and STAT5, J Immunol 201(1) 278-295. https:\/\/pubmed.ncbi.nlm.nih.gov\/29752311\/.","DOI":"10.4049\/jimmunol.1701069"},{"issue":"6","key":"10.1016\/j.cellimm.2023.104788_b0485","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4049\/jimmunol.1500957","article-title":"Inhibition of B lymphopoiesis by adipocytes and IL-1-producing myeloid-derived suppressor cells","volume":"195","author":"Kennedy","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0490","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.181.1.435","article-title":"Inhibition of tumor growth by elimination of granulocytes","volume":"181","author":"Pekarek","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2023.104788_b0495","first-page":"256","article-title":"Peritoneal T lymphocyte regulation by macrophages","volume":"215","author":"Composto","year":"2010","journal-title":"Immunobiology"},{"issue":"10177","key":"10.1016\/j.cellimm.2023.104788_b0500","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"8932","key":"10.1016\/j.cellimm.2023.104788_b0505","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(94)90749-8","article-title":"Parity, age at first childbirth, and risk of ovarian cancer","volume":"344","author":"Adami","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2023.104788_b0510","unstructured":"Biomarkers of Aging. Of Mice and Men: Translating Mouse Age to Human Age, https:\/\/www.gowinglife.com\/of-mice-and-men-translating-mouse-age-to-human-age\/, posted on 22 September 2021, (accessed 23 October 2023)."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104788_b0515","doi-asserted-by":"crossref","first-page":"e24420","DOI":"10.1371\/journal.pone.0024420","article-title":"Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis","volume":"6","author":"Bankert","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cellimm.2023.104788_b0520","first-page":"475","article-title":"Phenotype of lymphocyte in ovarian tumor peritoneal fluid","volume":"13","author":"Lacki","year":"1992","journal-title":"A Preliminary Study, Eur J Gynaecol Oncol"},{"issue":"5","key":"10.1016\/j.cellimm.2023.104788_b0525","first-page":"708","article-title":"Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer","volume":"64","author":"Berek","year":"1984","journal-title":"Obste Gynecol"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0171-2985(11)80263-9","article-title":"FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients","volume":"191","author":"Reijnhart","year":"1994","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104788_b0535","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(79)91172-0","article-title":"Ovarian cancer: a solid tumor with evidence of normal cellular immune function but abnormal B cell function","volume":"66","author":"Mandell","year":"1979","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0540","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/intimm\/1.1.75","article-title":"Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity","volume":"1","author":"Kroese","year":"1989","journal-title":"Int. Immunol."},{"issue":"5474","key":"10.1016\/j.cellimm.2023.104788_b0545","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1126\/science.288.5474.2222","article-title":"A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria","volume":"288","author":"MacPherson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2023.104788_b0550","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity, 591(7850)","author":"Biswas","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0555","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-023-02680-7","article-title":"TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer","volume":"42","author":"Zorea","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104788_b0560","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.201343418","article-title":"Peritoneal cavity B-1a cells promote peripheral CD4+ T-cell activation","volume":"43","author":"Margry","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"6101","key":"10.1016\/j.cellimm.2023.104788_b0565","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.1220961","article-title":"Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses","volume":"337","author":"Hand","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2023.104788_b0570","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0575","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF--mediated silencing of genomic organizer SATB1 promotes Tfh differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cellimm.2023.104788_b0580","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/0008-5472.CAN-10-4627","article-title":"Interleukin-10 ablation promotes tumor development, growth, and metastasis","volume":"72","author":"Tanaka","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0585","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cellimm.2023.104788_b0590","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","article-title":"Tumor-reactive antibodies evolve from non-binding and autoreactive precursors","volume":"185","author":"Mazor","year":"2022","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cellimm.2023.104788_b0595","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.4049\/jimmunol.2200447","article-title":"Natural antibodies alert the adaptive immune system of the presence of transformed cells in early tumorigenesis","volume":"209","author":"Rawat","year":"2022","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2023.104788_b0600","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7791","key":"10.1016\/j.cellimm.2023.104788_b0605","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0610","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-16-0081","article-title":"A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases","volume":"23","author":"Monfort","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellimm.2023.104788_b0615","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104788_b0620","doi-asserted-by":"crossref","first-page":"e54029","DOI":"10.1371\/journal.pone.0054029","article-title":"Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874923001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874923001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:11:34Z","timestamp":1757805094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874923001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":124,"alternative-id":["S0008874923001272"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104788","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of B1 and marginal zone B cells during ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104788"}}